If there’s one person who helped shake the stigma of bowel cancer in the young, it was the late Dame Deborah James. The ...

A diet deficient in calcium was considered the highest risk factor, linked to approximately one in five deaths from colon ...

Aspirin use in patients with PI3K-mutated colorectal cancer helped to reduce disease recurrence, highlighting the importance ...

Bristol Myers Squibb (BMY) says its cancer drugs Opdivo and Yervoy improved progression-free survival in a Phase 3 trial for ...

Neoadjuvant Keytruda for patients with deficient DNA mismatch repair colon cancer resulted in a pathological complete ...

Pfizer (PFE) colorectal cancer therapy Braftovi as part of a drug combo indicates a favorable objective response rate in a ...

Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefited from first-line treatment with the targeted therapies encorafenib and cetuximab plus a mFOLFOX6 chemotherapy ...

Old drugs from Bristol Myers Squibb and Pfizer have delivered what the companies and researchers believe could establish them ...

Metastatic colorectal cancer with microsatellite instability-high or mismatch repair-deficient status represents a distinct ...

Rates of colon cancer have risen more than 20% since 1995 with people in their 30s and even their 20s being diagnosed with a ...

The CDC advises 45- to 75 year olds to get screened for colorectal cancer regularly. However, the American Cancer Society's statistics show that it is on the rise among people under the age of 50, ...

Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefitted from first-line treatment with ...